Novartis Drops Plan for Major Trial in UK, FT Reports
22 Março 2023 - 7:36AM
Dow Jones News
--Novartis AG has dropped a plan to conduct a major trial for
its cholesterol drug Leqvio in the U.K. in collaboration with the
National Health Service and will run a global trial instead, the
Financial Times reports.
--The decision followed a low take-up of the drug during the
initial U.K. rollout, the FT reports.
--The Swiss pharmaceutical company didn't immediately respond to
a request for comment when contacted by Dow Jones Newswires.
Full story: https://on.ft.com/3luXQMA
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
March 22, 2023 06:21 ET (10:21 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
